Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Meyerson

Showing results (81-90 of 387) with videos related to

Pageof 39
Sort By:
International Journal of Oncology|January 19, 2008
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomasIngeborg B Engelsen, Ingunn M Stefansson, Rameen Beroukhim, et al.
Cancer Research|December 10, 2014
Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesotheliomaGuangwu Guo, Juliann Chmielecki, Chandra Goparaju, et al.
Genome Medicine|August 3, 2022
Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumorsNetta Mäkinen, Meng Zhou, Zhouwei Zhang, et al.
Nature|May 29, 2015
Chromothripsis from DNA damage in micronucleiCheng-Zhong Zhang, Alexander Spektor, Hauke Cornils, et al.
Human Mutation|February 24, 2015
Oncotator: cancer variant annotation toolAlex H Ramos, Lee Lichtenstein, Manaswi Gupta, et al.
Nature Chemical Biology|November 12, 2025
Publisher Correction: Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugsAnanthan Sadagopan, Maximilian Carson, Eriks J Zamurs, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2006
C/EBP alpha mutations in lung cancerDaniel B Costa, Tajhal Dayaram, Francesco D'Alo, et al.
ACS Chemical Biology|September 22, 2015
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung CancerHideki Terai, Li Tan, Ellen M Beauchamp, et al.
Nature Chemical Biology|November 3, 2025
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugsAnanthan Sadagopan, Maximilian Carson, Eriks J Zamurs, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
<i>XRN1</i> deletion induces PKR-dependent cell lethality in interferon-activated cancer cellsTao Zou, Meng Zhou, Akansha Gupta, et al.
Pageof 39

Showing results (81-90 of 387) with videos related to

Sort By:
Pageof 39
International Journal of Oncology|January 19, 2008
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomasIngeborg B Engelsen, Ingunn M Stefansson, Rameen Beroukhim, et al.
Cancer Research|December 10, 2014
Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesotheliomaGuangwu Guo, Juliann Chmielecki, Chandra Goparaju, et al.
Genome Medicine|August 3, 2022
Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumorsNetta Mäkinen, Meng Zhou, Zhouwei Zhang, et al.
Nature|May 29, 2015
Chromothripsis from DNA damage in micronucleiCheng-Zhong Zhang, Alexander Spektor, Hauke Cornils, et al.
Human Mutation|February 24, 2015
Oncotator: cancer variant annotation toolAlex H Ramos, Lee Lichtenstein, Manaswi Gupta, et al.
Nature Chemical Biology|November 12, 2025
Publisher Correction: Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugsAnanthan Sadagopan, Maximilian Carson, Eriks J Zamurs, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2006
C/EBP alpha mutations in lung cancerDaniel B Costa, Tajhal Dayaram, Francesco D'Alo, et al.
ACS Chemical Biology|September 22, 2015
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung CancerHideki Terai, Li Tan, Ellen M Beauchamp, et al.
Nature Chemical Biology|November 3, 2025
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugsAnanthan Sadagopan, Maximilian Carson, Eriks J Zamurs, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
<i>XRN1</i> deletion induces PKR-dependent cell lethality in interferon-activated cancer cellsTao Zou, Meng Zhou, Akansha Gupta, et al.
Pageof 39